Monograph 0478 imposes stricter criteria for non-standard tablets.
Control active substance release behavior throughout the digestive tract. Key Quality Control and Physical Testing Requirements European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
The monograph requires a visual description of the tablets (color, shape, markings). More critically, it mandates a specific identification test for the active substance(s), typically using High-Performance Liquid Chromatography (HPLC) or Infrared (IR) spectroscopy. This prevents mix-ups and ensures the correct drug is present. More critically, it mandates a specific identification test
The legal status of the Ph. Eur. is defined by the Convention on the Elaboration of a European Pharmacopoeia (1964). In EU law, any medicine seeking a Marketing Authorization (via the centralized, decentralized, or national procedure) must comply with the relevant Ph. Eur. monographs. Thus, Monograph 0478 is not a guideline but a . A batch of tablets failing the dissolution or uniformity test is considered adulterated and cannot be released to the market. Eur. monographs. Thus
%EB%A7%88%EC%9D%B4%EB%A6%AC%EC%96%BC%ED%8A%B8%EB%A6%BD.jpg)
%EC%84%BC%ED%8A%B8%EB%B9%84.png)
%25EB%259D%25BC%25EC%259D%25B4%25EC%2596%25B8%25EB%25A1%259C%25EC%25BC%2593%2520%25EB%25A1%259C%25EA%25B3%25A0.png)
h2o.png)
.png)
%25EC%2596%25B8%25EC%25BB%25A4%25EB%25A8%25BC%25ED%2599%2588%2520%25EB%25A1%259C%25EA%25B3%25A0.png)
%25ED%258F%25B0%25EA%25B0%2580%25EB%25B9%2584.png)
